International Biotechnology Ord (IBT.L) Stock

IBT.L logo

International Biotechnology Ord

IBT.L
Healthcare

Company profile

Largest shareholders

  • Border to Coast Pensions Partnership Ltd.11.71%
  • Raymond James Wealth Management Ltd. (Investment Management)5.63%
  • Schroder & Co Bank AG (Private Banking)4.57%
  • Hargreaves Lansdown Asset Management Ltd.4.25%
  • West Yorkshire Pension Fund (Investment Management)4.04%

Share of the company, as of September 25, 2026

What companies are similar to International Biotechnology Ord?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include UCB SA (0NZT.IL), Grifols, S.a. (0RDV.IL), Hikma Pharmaceuticals PLC (HIK.L), Beximco Pharmaceuticals Limited (BXP.L).

Company Information

SectorHealthcare
IndustryMulti-Therapeutic Drug Manufacturing
Founded1994
IPO DateMay 6, 1994
IPO StatusPublic
ExchangeLSE
TimezoneEurope/London (GMT)

Contact & Links

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.

Data as of .

How to cite: DataPorium, “International Biotechnology Ord (IBT.L)”, data as of Sep 25, 2026, https://dataporium.tech/stocks/IBT.L

LinkedInLinkedInXXYouTubeYouTube